Claritev Corporation (CTEV)
NYSE: CTEV · Real-Time Price · USD
22.65
+0.08 (0.35%)
Apr 25, 2025, 11:32 AM EDT - Market open
Claritev Market Cap
Claritev has a market cap or net worth of $366.89 million as of April 25, 2025. Its market cap has decreased by -32.53% in one year.
Market Cap
366.89M
Enterprise Value
4.90B
1-Year Change
-32.53%
Ranking
Category
Stock Price
$22.65
Market Cap Chart
Since April 3, 2020, Claritev's market cap has increased from $243.00M to $366.89M, an increase of 50.98%. That is a compound annual growth rate of 8.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 24, 2025 | 365.59M | 52.96% |
| Dec 31, 2024 | 239.01M | -74.44% |
| Dec 29, 2023 | 935.26M | 27.25% |
| Dec 30, 2022 | 734.99M | -74.01% |
| Dec 31, 2021 | 2.83B | -46.98% |
| Dec 31, 2020 | 5.33B | 2,094.66% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 735.45B |
| UnitedHealth Group | 385.29B |
| Johnson & Johnson | 377.55B |
| AbbVie | 305.27B |
| Novo Nordisk | 266.18B |
| Abbott Laboratories | 226.81B |
| Novartis AG | 209.93B |
| AstraZeneca | 208.11B |